Juan Camilo Arjona Ferreira - Jan 4, 2022 Form 4 Insider Report for Myovant Sciences Ltd. (MYOV)

Role
Chief Medical Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Stock symbol
MYOV
Transactions as of
Jan 4, 2022
Transactions value $
-$36,949
Form type
4
Date filed
1/6/2022, 03:21 PM
Previous filing
Dec 1, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale -$36.9K -2.27K -1.36% $16.27 164K Jan 4, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.